(Q33361713)

26 July 2017

1 reference

title

Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review (English)

1 reference

26 July 2017

1 reference

Jeffrey S Dlott

1

1 reference

26 July 2017

Constance F M Danielson

series ordinal

2

1 reference

26 July 2017

Deborah E Blue-Hnidy

series ordinal

3

1 reference

26 July 2017

Leo J McCarthy

series ordinal

4

1 reference

26 July 2017

1 April 2004

1 reference

Therapeutic Apheresis and Dialysis

26 July 2017

1 reference

26 July 2017

8

1 reference

26 July 2017

2

1 reference

26 July 2017

102-111

1 reference

Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Haemolysis and renal impairment syndrome in patients on 5-fluorouracil and mitomycin-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic–uremic syndrome due to gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Renal vascular and thrombotic effects of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Induction of thromboses within renal grafts by high-dose prophylactic OKT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic microangiopathy in a patient with chronic myelocytic leukaemia treated with alpha-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Vascular events associated with alpha interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Quinine-mediated disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenic purpura associated with clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenic purpura related to ticlopidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Hemolytic uremic syndrome associated with clopidogrel: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Ciprofloxacin-associated hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenic purpura in a patient treated with clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenia purpura caused by piperacillin successfully treated with plasma infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Microangiopathic Hemolysis and Thrombocytopenia Related to Penicillin Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Thrombohemolytic Thrombocytopenic Purpura During Penicillamine Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Cocaine-induced microangiopathic hemolytic anemia and thrombocytopenia simulating thrombotic thrombocytopenia purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Haemolytic-uraemic syndrome in a heroin addict

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Application of peroxidase-labeled antibody methods to identification of immunoglobulin-containing cells in gastrointestinal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

Fatal systemic reaction after multiple doses of intravesical bacillus Calmette-Guérin for polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-0968.2003.00127.X

10.1111/J.1526-0968.2003.00127.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference